Lipum AB Sustainability Reports
Lipum AB is a clinical-stage biopharmaceutical company focused on discovering and developing novel biological treatments for chronic inflammatory diseases.
Sector: Manufacturing
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300V7JL0004BHBD93
FIGI: BBG00DQ5HC60
1 reports from 2020 to 2020